vs
Opus Genetics, Inc.(IRD)与AIRWA INC.(YYAI)财务数据对比。点击上方公司名可切换其他公司
Opus Genetics, Inc.的季度营收约是AIRWA INC.的1.3倍($3.9M vs $3.0M),AIRWA INC.同比增速更快(729.8% vs -10.2%),过去两年Opus Genetics, Inc.的营收复合增速更高(50.3% vs 14.3%)
Opus Genetics是一家临床阶段生物技术企业,专注开发针对遗传性视网膜疾病的靶向基因疗法,致力于为患有罕见致盲性眼部疾病的患者解决未被满足的医疗需求,核心业务为面向全球罕见病市场推进可及性治疗候选药物的研发工作。
Flying W航空公司(FWA)起源于1961年,创始人在新泽西开设了Flying W机场,打造可通航降落的度假胜地,在20世纪60年代末70年代初曾是知名度较高的上市企业。该公司押注阿拉斯加石油开发,1969年发展至巅峰,吸引了马特拉克家族投资,还吸纳两名好莱坞演员加入董事会,并收购了阿拉斯加的Red Dodge航空,购入飞机借阿拉斯加输油管道项目谋求发展。
IRD vs YYAI — 直观对比
营收规模更大
IRD
是对方的1.3倍
$3.0M
营收增速更快
YYAI
高出739.9%
-10.2%
两年增速更快
IRD
近两年复合增速
14.3%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $3.9M | $3.0M |
| 净利润 | — | $-221.8K |
| 毛利率 | — | 75.2% |
| 营业利润率 | — | 1.8% |
| 净利率 | — | -7.4% |
| 营收同比 | -10.2% | 729.8% |
| 净利润同比 | 53.0% | 83.8% |
| 每股收益(稀释后) | — | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
IRD
YYAI
| Q4 25 | $3.9M | $3.0M | ||
| Q3 25 | $3.1M | $3.0M | ||
| Q2 25 | $2.9M | $3.0M | ||
| Q1 25 | $4.4M | $3.3M | ||
| Q4 24 | $4.3M | $3.3M | ||
| Q3 24 | $3.9M | $3.3M | ||
| Q2 24 | $1.1M | $-701.1K | ||
| Q1 24 | $1.7M | — |
净利润
IRD
YYAI
| Q4 25 | — | $-221.8K | ||
| Q3 25 | $-17.5M | $1.3M | ||
| Q2 25 | $-7.4M | $552.2K | ||
| Q1 25 | $-8.2M | $-411.2K | ||
| Q4 24 | — | $-1.4M | ||
| Q3 24 | $-7.5M | $-4.2M | ||
| Q2 24 | $-7.8M | — | ||
| Q1 24 | $-7.1M | — |
毛利率
IRD
YYAI
| Q4 25 | — | 75.2% | ||
| Q3 25 | — | 75.2% | ||
| Q2 25 | — | 75.2% | ||
| Q1 25 | — | 77.3% | ||
| Q4 24 | — | 77.3% | ||
| Q3 24 | — | 77.3% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率
IRD
YYAI
| Q4 25 | — | 1.8% | ||
| Q3 25 | -269.9% | 49.7% | ||
| Q2 25 | -309.0% | 42.7% | ||
| Q1 25 | -227.2% | 16.2% | ||
| Q4 24 | — | 71.2% | ||
| Q3 24 | -207.1% | 74.6% | ||
| Q2 24 | -748.9% | — | ||
| Q1 24 | -450.5% | — |
净利率
IRD
YYAI
| Q4 25 | — | -7.4% | ||
| Q3 25 | -566.9% | 42.0% | ||
| Q2 25 | -257.5% | 18.4% | ||
| Q1 25 | -187.5% | -12.6% | ||
| Q4 24 | — | -41.7% | ||
| Q3 24 | -194.6% | -129.0% | ||
| Q2 24 | -698.3% | — | ||
| Q1 24 | -415.3% | — |
每股收益(稀释后)
IRD
YYAI
| Q4 25 | — | $-0.05 | ||
| Q3 25 | $-0.25 | — | ||
| Q2 25 | $-0.12 | — | ||
| Q1 25 | $-0.24 | $-1.41 | ||
| Q4 24 | — | $6.43 | ||
| Q3 24 | $-0.29 | $-1.91 | ||
| Q2 24 | $-0.30 | $-30.98 | ||
| Q1 24 | $-0.29 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $45.1M | $107.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $15.3M | $165.4M |
| 总资产 | $50.2M | $172.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
IRD
YYAI
| Q4 25 | $45.1M | $107.0M | ||
| Q3 25 | $30.8M | $2.5M | ||
| Q2 25 | $32.4M | $1.4M | ||
| Q1 25 | $41.8M | $4.3M | ||
| Q4 24 | $30.3M | $18.1M | ||
| Q3 24 | $36.6M | $18.2M | ||
| Q2 24 | $41.4M | $1.8M | ||
| Q1 24 | $47.2M | — |
股东权益
IRD
YYAI
| Q4 25 | $15.3M | $165.4M | ||
| Q3 25 | $6.0M | $26.2M | ||
| Q2 25 | $17.5M | $25.3M | ||
| Q1 25 | $5.1M | $26.1M | ||
| Q4 24 | $6.7M | $8.0M | ||
| Q3 24 | $34.3M | $9.4M | ||
| Q2 24 | $40.6M | $9.6M | ||
| Q1 24 | $46.1M | — |
总资产
IRD
YYAI
| Q4 25 | $50.2M | $172.1M | ||
| Q3 25 | $36.1M | $34.7M | ||
| Q2 25 | $38.7M | $32.9M | ||
| Q1 25 | $48.2M | $30.7M | ||
| Q4 24 | $36.9M | $21.6M | ||
| Q3 24 | $40.4M | $23.2M | ||
| Q2 24 | $44.8M | $23.2M | ||
| Q1 24 | $51.8M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-35.3M | $-30.8M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
IRD
YYAI
| Q4 25 | $-35.3M | $-30.8M | ||
| Q3 25 | $-6.2M | $-1.1M | ||
| Q2 25 | $-10.3M | $-423.7K | ||
| Q1 25 | $-9.0M | $-133.8K | ||
| Q4 24 | $-25.6M | $779.4K | ||
| Q3 24 | $-5.1M | $-601.3K | ||
| Q2 24 | $-7.3M | $-460.3K | ||
| Q1 24 | $-5.7M | — |
现金转化率
IRD
YYAI
| Q4 25 | — | — | ||
| Q3 25 | — | -0.86× | ||
| Q2 25 | — | -0.77× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图